Alumis Inc.
ALMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847367
In the last 90 days, Alumis Inc. insiders filed 1 open-market purchase and 8 sales; 198 institutions reported holding it in 13F filings for Q2 2026, worth $3.32B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Alumis Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 130
- +18 vs. Q2 2025
- Shares held
- 78.0M
- −331.5K (−0.4%) vs. Q2 2025
- Total value
- $311.2M
- +$76.2M (+32.4%) vs. Q2 2025
- New holders
- 33
- 37 more added
- Sold out
- 15
- 31 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALMS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 198 | $3.32B |
| Q1 2026 | 197 | $2.53B |
| Q4 2025 | 134 | $771.1M |
| Q3 2025 | 130 | $311.2M |
| Q2 2025 | 112 | $235.0M |
| Q1 2025 | 72 | $246.8M |
| Q4 2024 | 64 | $316.5M |
| Q3 2024 | 52 | $376.1M |
| Q2 2024 | 29 | $380.0M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Alumis Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 417,080 | $1.66M | 0.00% | +284,970+215.7% | Added |
| Madison Avenue Partners, LP | 417,777 | $1.67M | 0.10% | −1,424,492−77.3% | Reduced |
| Northern Trust Corp | 438,972 | $1.75M | 0.00% | +60,666+16.0% | Added |
| Charles Schwab Investment Management Inc | 491,002 | $1.96M | 0.00% | +112,152+29.6% | Added |
| Towerview LLC | 495,000 | $1.98M | 1.44% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 653,223 | $2.61M | 1.17% | 00.0% | Unchanged |
| Opaleye Management Inc. | 665,000 | $2.65M | 0.38% | −110,000−14.2% | Reduced |
| UBS Group AG | 762,675 | $3.04M | 0.00% | −444,880−36.8% | Reduced |
| Fan Yu | 789,618 | $3.15M | 4.10% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 946,683 | $3.78M | 3.55% | −674,163−41.6% | Reduced |
| State Street Corp | 1,101,886 | $4.40M | 0.00% | −7,205−0.6% | Reduced |
| Tang Capital Management LLC | 1,167,009 | $4.66M | 0.18% | −829,788−41.6% | Reduced |
| BML Capital Management, LLC | 1,210,415 | $4.83M | 4.44% | 00.0% | Unchanged |
| General Atlantic LLC | 1,297,530 | $5.18M | 0.16% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,393,286 | $5.56M | 0.00% | +225,454+19.3% | Added |
| Tybourne Capital Management (HK) Ltd | 1,399,250 | $5.58M | 18.05% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,562,500 | $6.23M | 0.05% | 00.0% | Unchanged |
| Woodline Partners LP | 1,751,150 | $6.99M | 0.03% | +1,558,660+809.7% | Added |
| OrbiMed Advisors LLC | 1,926,423 | $7.69M | 0.18% | 00.0% | Unchanged |
| Sr One Capital Management, LP | 1,959,896 | $7.82M | 1.13% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 2,147,396 | $8.57M | 0.59% | 00.0% | Unchanged |
| Nextech Invest, Ltd. | 2,915,998 | $11.6M | 1.77% | 00.0% | Unchanged |
| Trium Capital LLP | 3,122,111 | $12.5M | 4.89% | +474,072+17.9% | Added |
| Vanguard Group Inc | 4,029,615 | $16.1M | 0.00% | +625,404+18.4% | Added |
| BlackRock, Inc. | 4,193,077 | $16.7M | 0.00% | +17,364+0.4% | Added |
| Foresite Capital Management VI LLC | 4,247,670 | $16.9M | 6.55% | 00.0% | Unchanged |
| venBio Partners LLC | 4,619,803 | $18.4M | 10.45% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 4,801,370 | $19.2M | 2.50% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 5,779,348 | $23.1M | 21.21% | 00.0% | Unchanged |
| AyurMaya Capital Management Company, LP | 15,139,706 | $60.4M | 100.00% | −10.0% | Reduced |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −559,201−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −351,138−100.0% | Sold out |
| Palo Alto Investors LP | 0 | $0 | 0.00% | −143,437−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −69,766−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −45,700−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −31,316−100.0% | Sold out |
| Carlson Capital L P | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −25,089−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −23,374−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −14,356−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −8,028−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| Glenmede Investment Management, LP | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |